Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.66 CAD | -.--% | +1.54% | -10.81% |
25/04 | Transcript : Valeo Pharma Inc. - Shareholder/Analyst Call | |
22/03 | Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors | CI |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals and Hospital Specialty Products
100.0
%
| 28 | 100.0 % | 54 | 100.0 % | +94.31% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 28 | 100.0 % | 54 | 100.0 % | +94.31% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Saviuk
FOU | Founder | 65 | 27/03/27 |
Pascal Tougas
DFI | Director of Finance/CFO | - | 20/11 |
Nelly Komari
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Frédéric Dumais
IRC | Investor Relations Contact | - | 01/19/01 |
Corporate Officer/Principal | - | 01/23/01 | |
Kyle Steiger
PRN | Corporate Officer/Principal | - | 30/22/30 |
David Newell
SAM | Sales & Marketing | - | 01/11/01 |
General Counsel | 56 | 25/16/25 | |
Guy-Paul Allard
LAW | General Counsel | 56 | 01/16/01 |
Helen Saviuk
PRN | Corporate Officer/Principal | 71 | 01/08/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard MacKay
CHM | Chairman | 89 | 25/18/25 |
Steven Saviuk
FOU | Founder | 65 | 27/03/27 |
Marc Léger
BRD | Director/Board Member | 65 | 27/22/27 |
Richard Lajoie
BRD | Director/Board Member | - | 07/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 98,675,427 | 52,181,062 ( 52.88 %) | 0 | 52.88 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- VPH Stock
- VPH Stock
- Company Valeo Pharma Inc.